US Wants Voice In Supreme Court Generic-Drug Showdown

Law360, New York (February 21, 2013, 5:30 PM EST) -- The U.S. solicitor general asked the Supreme Court on Wednesday to allow him to participate in oral arguments in an appeal of a First Circuit decision that held design defect claims against a generic-drug maker are not preempted by federal law.

Solicitor General Donald Verrilli Jr. filed the motion in a case that centers on a $23 million award to a woman, Karen Bartlett, who suffered a near-fatal reaction after taking a Mutual Pharmaceutical Co. Inc. drug for shoulder pain. The First Circuit held that, unlike...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.